Psychotropic Drug Directory March 2024 Update

The new formulations of 6 monthly paliperidone injection and the risperidone once monthly injection have been added including new projections for the predicted pharmacokinetic profiles (chapter 1) and initiation and switching (chapter 2) guidance. Daridorexant has been included for insomnia (chapter 1) along with additions to its use in problem areas (chapter 3). Enhanced the information on the use of esketamine in depression (chapter 1) and added information on the use of other psychedelics in chapter 1 and 4.  The withdrawal of antidepressants (chapter 2) was reviewed following the release of new guidance on that topic.